IR-Med Inc.

0.0339+0.00 (+0%)
Oct 28, 4:00:00 PM EDT · OTC Markets OTCQB · IRME · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
3.25M
P/E (TTM)
-
Basic EPS (TTM)
-0.03
Dividend Yield
0%

Recent Filings

About

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.

CEO
Mr. Oded Bashan
IPO
1/26/2021
Employees
3
Sector
Healthcare
Industry
Medical Devices